Clinical trial
Post Market TRUST - U.S.A. Study
NCT02163525 · Acessa Health, Inc., Industry · Completed
Key facts
| NCT number | NCT02163525 |
|---|---|
| Title | Post Market TRUST - U.S.A. Study |
| Official title | The TRUST (Treatment Results of Uterine Sparing Technologies) U.S.A. Study |
| Lead sponsor | Acessa Health, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Symptomatic Uterine Fibroids |
| Intervention type | Procedure |
| Interventions | Global Fibroid Ablation (GFA), Abdominal or Laparoscopic Myomectomy, Uterine Artery Embolization (UAE) |
| Enrollment | 114 |
| Start date | Jun 12, 2014 |
| Primary completion | Jul 1, 2019 |
| Completion | Sep 12, 2025 |
| First posted | Jun 13, 2014 |
| Last update posted | Sep 30, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: